Drugs Made In America Acquisition II Corp. (NasdaqGM: DMII)
Financials · Capital Markets · US
$10.19
0.00% today · +3.1% 1Y
Drugs Made In America Acquisition II Corp. (NasdaqGM: DMII) operates in the Capital Markets industry within the Financials sector. The company is valued at $649.10M and employs 2 people.
Over the last twelve months the share price has gained 3.1%, trading between 9.86 and 10.33.
Tweenvest scores Drugs Made In America Acquisition II Corp. across four factors: quality 20/100, value 73/100. Its strongest factor is value.
DMII price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $649.10M
- Revenue (TTM)
- —
- P/E
- 41.64
- EPS
- 0.24
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $10.33
- 52-week low
- $9.86
- Avg volume (3M)
- —
- Shares outstanding
- 63.70M
- Employees
- 2
- Next earnings
- —
About Drugs Made In America Acquisition II Corp.
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company was founded in 2024 and maintains its principal office in Fort Lauderdale, Florida.
- ISIN
- KYG2851K1040
- Founded
- 2024
- Listed since
- Dec 4, 2025
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Brait PLCJSE: BAT | $662.16M | R2.00 | -3.85% |
| Yuanta Securities Korea Co., Ltd.KOSE: A003470 | $661.88M | ₩4,350.00 | -1.36% |
| iShares Trust - iShares Morningstar Small-Cap Value ETFARCA: ISCV | $660.54M | $75.49 | -0.93% |
| Administradora Americana de Inversiones S.A.SNSE: AAISA | $652.31M | CL$640.00 | +1.19% |
| Foresight Group Holdings LimitedLSE: FSG | $637.92M | £4.37 | -2.67% |
| New Mountain Finance CorporationNasdaqGS: NMFC | $636.61M | $6.81 | +1.04% |
| CoinShares PLCNasdaqGS: CSHR | $635.18M | $4.63 | -3.94% |
| OTC Markets Group Inc.OTCPK: OTCM | $634.40M | $53.90 | +0.17% |
Figures last refreshed Oct 4, 2026.